Competitor Counterclaim Survives Early Dismissal Bid

Footwear accessories operators should expect competitor counterclaims over sales-rep dealings to move past the pleading stage into costly discovery.

Updated on Nov. 16, 2026 in Healthcare

Empty stone plaza in front of a plain brick and limestone courthouse, with a stack of unmarked folders on a bench in the foreground.
North Carolina's Business Court on Monday denied footwear accessories maker Implus Footcare's bid to dismiss a counterclaim by competitor Blue San, which alleges unfair trade practices over shared sales reps. AI Illustration. Upload story photo >

North Carolina's Business Court denied footwear accessories maker Implus Footcare's motion for partial judgment on the pleadings, allowing a counterclaim alleging unfair and deceptive trade practices by a newer competitor to proceed in full. The ruling, issued in November 2026, affects how companies in the North Carolina footwear accessories sector may face competitive litigation.

Why it matters

The court found that whether Implus's conduct was protected by litigation immunity or a learned profession exemption depends on factual questions that cannot be resolved without a fuller record. For operators, the ruling signals that a competitor's lawsuit and related communications with shared sales representatives can become the subject of a costly counterclaim that proceeds past the pleading stage.

The counterclaim alleges conduct across ten categories of unfair practices, and the opinion is 11 pages long (2026 NCBC 34). The court's ruling is preliminary, addressing only the sufficiency of the pleadings rather than the merits of either side's claims.

The players

Implus Footcare LLC

A longstanding footwear accessories company whose operating history predates the newer competitor in this dispute.

The details

Blue San alleges that Implus attempted to bribe sales representatives it shared with Blue San, induced breaches of contract, and threatened litigation as part of a coordinated effort to stifle its market entry. Implus countered that Blue San's reliance on the filing and maintenance of the lawsuit cannot support an unfair and deceptive trade practices claim, and argued that the Noerr-Pennington doctrine and a learned profession exemption shield its litigation-related communications. The court declined to resolve either defense at this stage, reasoning that both turn on facts not yet developed in the record.

Timeline

  1. November 15, 2026: North Carolina Business Court issues the ruling denying Implus's motion for partial judgment on the pleadings.

Market Landscape

The ruling reflects a pattern in which antitrust-style immunity defenses such as Noerr-Pennington are often fact-dependent and rarely dispose of a case on the pleadings. Competitive disputes in niche consumer-goods sectors, where former executives launch rival firms, increasingly play out through counterclaims in specialized state business courts.

Operators in footwear and accessories should expect that competitor lawsuits and related outreach to shared sales representatives may generate counterclaims that survive early motions and require discovery. Legal and compliance teams should review how sales-channel communications are documented, and any specific exposure should be assessed with qualified counsel.

The takeaway

The key operating insight is that a fact-dependent defense can keep a counterclaim alive for months, raising litigation cost even where the underlying claim is disputed. Businesses should track the case's progression toward summary judgment and, with qualified counsel, review their own sales-representative and dispute-related communications for compliance risk.

Further reading

For context on how litigation disputes shape competitive conduct in regulated markets, explore the Healthcare coverage on We are Main Street.

Source note: This article includes information reported by North Carolina Lawyers Weekly.